Oppenheimer & Co’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-12,764
| Closed | -$408K | – | 1489 |
|
|
2022
Q2 | $408K | Buy |
12,764
+1,015
| +9% | +$32.4K | 0.01% | 991 |
|
|
2022
Q1 | $407K | Buy |
11,749
+422
| +4% | +$14.6K | 0.01% | 1079 |
|
|
2021
Q4 | $332K | Buy |
+11,327
| New | +$332K | 0.01% | 1186 |
|
|
2021
Q3 | – | Sell |
-21,665
| Closed | -$759K | – | 1601 |
|
|
2021
Q2 | $759K | Buy |
21,665
+5,863
| +37% | +$205K | 0.01% | 857 |
|
|
2021
Q1 | $644K | Sell |
15,802
-13,226
| -46% | -$539K | 0.01% | 861 |
|
|
2020
Q4 | $1.26M | Buy |
29,028
+12,901
| +80% | +$559K | 0.03% | 570 |
|
|
2020
Q3 | $889K | Sell |
16,127
-2,895
| -15% | -$160K | 0.02% | 627 |
|
|
2020
Q2 | $1.2M | Buy |
19,022
+10,987
| +137% | +$694K | 0.03% | 509 |
|
|
2020
Q1 | $411K | Sell |
8,035
-3,966
| -33% | -$203K | 0.01% | 800 |
|
|
2019
Q4 | $954K | Buy |
12,001
+4,636
| +63% | +$369K | 0.02% | 639 |
|
|
2019
Q3 | $357K | Sell |
7,365
-3,865
| -34% | -$187K | 0.01% | 921 |
|
|
2019
Q2 | $591K | Buy |
11,230
+2,086
| +23% | +$110K | 0.02% | 750 |
|
|
2019
Q1 | $484K | Sell |
9,144
-5,526
| -38% | -$292K | 0.01% | 838 |
|
|
2018
Q4 | $602K | Sell |
14,670
-1,227
| -8% | -$50.4K | 0.02% | 677 |
|
|
2018
Q3 | $604K | Buy |
15,897
+3,700
| +30% | +$141K | 0.02% | 785 |
|
|
2018
Q2 | $552K | Buy |
12,197
+7,751
| +174% | +$351K | 0.02% | 826 |
|
|
2018
Q1 | $215K | Buy |
+4,446
| New | +$215K | 0.01% | 1188 |
|